- the
brand name Rezdiffra, is a
medication used for the
treatment of
noncirrhotic nonalcoholic steatohepatitis. It is a
thyroid hormone receptor beta (NR1A2)...
- used for
tissues with high
water content and low
fiber content, like
noncirrhotic liver and pancreas. It has
advantages of less
blood loss,
improved visibility...
- doi:10.1016/j.amjmed.2008.02.014. PMID 18456028.
Friedman LS (2020). "
Noncirrhotic Portal Hypertension". In
Papadakis MA,
McPhee SJ,
Rabow MW (eds.). Current...
-
integration of the
viral genome into
infected cells can
directly induce a
noncirrhotic liver to
develop HCC. Alternatively,
repeated consumption of
large amounts...
-
medical use in the
United States in
March 2024 for the
treatment of
noncirrhotic nonalcoholic steatohepatitis. Aspirin, 81 mg for 6 months, significantly...
- Jan 2021). "Cilofexor, a
Nonsteroidal FXR Agonist, in
Patients With
Noncirrhotic NASH: A
Phase 2
Randomized Controlled Trial". Hepatology. 72 (1): 58–71...
- (14
November 1985). "Survival and
Causes of
Death in
Cirrhotic and in
Noncirrhotic Patients with
Primary Hemochromatosis". New
England Journal of Medicine...
- of
ribavirin use,
prior interferon-based therapy, or
restriction on
noncirrhotic patients, IL28B genotype, or
baseline resistance-****ociated variants...
- Nath; J. R. Talwar; N. C. Nayak; B.N. Tandon; K. L. Wig (August 1971). "
Noncirrhotic portal fibrosis".
American Journal of Medicine. 51 (2): 160–169. doi:10...
- "Grazoprevir-Elbasvir
Combination Therapy for Treatment-Naive
Cirrhotic and
Noncirrhotic Patients With
Chronic Hepatitis C
Virus Genotype 1, 4, or 6 Infection:...
